Prescription Drug Spending Under The MMA: Modeling The Impact On Out-of-Pocket Costs
This report projects the impact of the new Medicare drug benefit on out-of-pocket spending for people who enroll in 2006. The analysis is based on a model developed by the Actuarial Research Corporation for the Kaiser Family Foundation. The model generally conforms to the Congressional Budget Office’s assumptions and projections about Medicare drug benefit spending and participation rates for the new benefit and for the low-income subsidy. The report was released at a briefing in Washington on November 22, 2004.
This analysis estimates that 6.9 million beneficiaries are projected to be affected by the coverage gap (the so-called “doughnut hole”) in the standard Part D drug benefit. This estimate is based on projected enrollment in Part D plans of 29 million (Congressional Budget Office, July 2004), prior to implementation of the drug benefit and actual enrollment in Part D plans.
Materials From the November 22, 2004 Briefing:
also of interest
- Financial and Administrative Alignment Demonstrations for Dual Eligible Beneficiaries Compared: States with Memoranda of Understanding Approved by CMS
- Long-Term Services and Supports in the Financial Alignment Demonstrations for Dual Eligible Beneficiaries
- Medicare at a Glance
- Understanding The Effects of The Medicare Part D Coverage Gap in 2008 and 2009